📊 RDGL Key Takeaways
Is RDGL a Good Investment? Thesis Analysis
VIVOS operates with fundamentally broken unit economics, evidenced by negative gross margins of -87.4% on minimal revenue of only 68.4K. The company is burning 2.1M in operating cash annually against 1.6M in cash reserves, providing less than one year of runway with no clear path to profitability or revenue recovery (down 31% YoY).
Operations remain pre-commercial with negligible revenue, deeply negative gross margin, and severe operating losses. Despite a cash-heavy, low-debt balance sheet, the burn rate far exceeds cash generation, implying likely external financing and dilution risk. Until unit economics turn positive and revenue scales, fundamentals are unfavorable.
Why Buy RDGL? Key Strengths
- Exceptional liquidity with 14.0x current ratio and 13.52x quick ratio provides short-term stability
- Very low debt burden with 0.02x debt-to-equity ratio and minimal interest obligations
- Positive stockholders equity of 1.7M provides modest balance sheet cushion
- Strong liquidity (current ratio 14x) with $1.56M cash vs. modest liabilities
- Very low leverage (D/E 0.02x; long-term debt $35.85K)
- Clean balance sheet offers short-term runway to execute
RDGL Investment Risks to Consider
- Negative gross margins (-87.4%) indicate fundamental business model failure or unsustainable pricing
- Revenue collapsing 31% YoY with only 68.4K in total sales demonstrates severe commercial challenges
- Operating cash burn of 2.1M annually against 1.6M cash reserves creates imminent solvency crisis within 12 months
- Deeply negative returns (ROE -184.6%, ROA -164.2%) with zero profitable quarters visible
- Minimal insider confidence with zero Form 4 filings in last 90 days
- Minimal revenue base and negative gross margin indicate non-viable unit economics
- High cash burn (OCF -$2.06M; FCF -$2.16M) relative to cash balance, raising dilution/financing risk
- Severely negative profitability metrics (operating/net margins, ROE/ROA) suggest going-concern pressure
Key Metrics to Watch
- Quarterly revenue trend and gross margin trajectory toward profitability
- Cash burn rate and months of liquidity remaining
- Operating cash flow return to positive and path to breakeven
- Gross margin
- Operating cash flow
RDGL Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 14.00x current ratio provides a solid financial cushion.
RDGL Profitability Ratios
RDGL vs Healthcare Sector
How VIVOS INC compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is RDGL Overvalued or Undervalued?
Based on fundamental analysis, VIVOS INC has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
RDGL Balance Sheet & Liquidity
RDGL 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: VIVOS INC's revenue has grown significantly by 359% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.01 indicates the company is currently unprofitable.
RDGL Growth Metrics (YoY)
RDGL Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $1.9K | -$503.5K | $0.00 |
| Q2 2025 | $13.5K | -$503.5K | $0.00 |
| Q1 2025 | $4.5K | -$558.5K | $0.00 |
| Q3 2024 | $5.0K | -$248.3K | $0.00 |
| Q2 2024 | $6.5K | -$248.3K | $0.00 |
| Q1 2024 | $4.5K | -$248.3K | $0.00 |
| Q3 2023 | $6.5K | -$248.3K | $0.00 |
| Q2 2023 | $6.5K | -$248.3K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
RDGL Capital Allocation
RDGL SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for VIVOS INC (CIK: 0001449349)
📋 Recent SEC Filings
❓ Frequently Asked Questions about RDGL
What is the AI rating for RDGL?
VIVOS INC (RDGL) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 88% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are RDGL's key strengths?
Claude: Exceptional liquidity with 14.0x current ratio and 13.52x quick ratio provides short-term stability. Very low debt burden with 0.02x debt-to-equity ratio and minimal interest obligations. ChatGPT: Strong liquidity (current ratio 14x) with $1.56M cash vs. modest liabilities. Very low leverage (D/E 0.02x; long-term debt $35.85K).
What are the risks of investing in RDGL?
Claude: Negative gross margins (-87.4%) indicate fundamental business model failure or unsustainable pricing. Revenue collapsing 31% YoY with only 68.4K in total sales demonstrates severe commercial challenges. ChatGPT: Minimal revenue base and negative gross margin indicate non-viable unit economics. High cash burn (OCF -$2.06M; FCF -$2.16M) relative to cash balance, raising dilution/financing risk.
What is RDGL's revenue and growth?
VIVOS INC reported revenue of $68.4K.
Does RDGL pay dividends?
VIVOS INC does not currently pay dividends.
Where can I find RDGL SEC filings?
Official SEC filings for VIVOS INC (CIK: 0001449349) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is RDGL's EPS?
VIVOS INC has a diluted EPS of $-0.01.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is RDGL a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, VIVOS INC has a STRONG SELL rating with 88% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is RDGL stock overvalued or undervalued?
Valuation metrics for RDGL: ROE of -184.6% (sector avg: 15%), net margin of -4,483.9% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy RDGL stock in 2026?
Our dual AI analysis gives VIVOS INC a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is RDGL's free cash flow?
VIVOS INC's operating cash flow is $-2.1M, with capital expenditures of $103.2K. FCF margin is -3,160.2%.
How does RDGL compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -4,483.9% (avg: 12%), ROE -184.6% (avg: 15%), current ratio 14.00 (avg: 2).